UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

The lancet oncology, 2018-04, Vol.19 (4), p.521-536

2018

Volltextzugriff (PDF)

The potentially underestimated influence of atrial fibrillation on NT-proBNP in chest pain

Europace (London, England), 2024-05, Vol.26 (Supplement_1)

2024

Volltextzugriff (PDF)

Role and potential of the circular economy in managing end-of-life ships in China

Resources, conservation and recycling, 2021-01, Vol.164, p.105039-105039, Article 105039

2021

Volltextzugriff (PDF)

Bildungsprozesse im Ganztag: Wahrnehmung und Wertung erweiterter Bildungsgelegenheiten durch Kinder

Staudner, Stephanie

1. Aufl. 2018 edition., 2017

Volltextzugriff (PDF)

Lipophilic Methanethiosulfonate (MTS) Reagents Inhibit Ion Channel Function of Polycystin-2 With a Gain-of-Function Mutation (F604P): FR-PO266

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.398-398

2022

Volltextzugriff (PDF)

Electrophysiological Characterization of Polycystin-2 Mutants With Disease-Associated Missense Mutations in the Channel's Pore Loop: FR-PO265

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.398-398

2022

Volltextzugriff (PDF)

Static modelling of the material flows of micro- and nanoplastic particles caused by the use of vehicle tyres

Environmental pollution (1987), 2021-12, Vol.290, p.118102-118102, Article 118102

2021

Volltextzugriff (PDF)

Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

BMC nephrology, 2024-02, Vol.25 (1), p.52-52, Article 52

2024

Volltextzugriff (PDF)

Disease-associated missense mutations in the pore loop of polycystin-2 alter its ion channel function in a heterologous expression system

The Journal of biological chemistry, 2024-08, Vol.300 (8), p.107574, Article 107574

2024

Volltextzugriff (PDF)

Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19

Kidney & blood pressure research, 2023-01, Vol.48 (1), p.424-435

2023

Volltextzugriff (PDF)

Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice

Pflügers Archiv, 2022-02, Vol.474 (2), p.217-229

2022

Volltextzugriff (PDF)

Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19

Journal of nephrology, 2021-08, Vol.34 (4), p.1007-1018

2021

Volltextzugriff (PDF)

Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates

Clinical and experimental medicine, 2023-12, Vol.23 (8), p.4919-4935

2023

Volltextzugriff (PDF)

Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen

Nephrology, dialysis, transplantation, 2017-04, Vol.32 (4), p.730-737

2017

Volltextzugriff (PDF)

XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice

Journal of the American Society of Nephrology, 2023-01, Vol.34 (1), p.110-121

2023

Volltextzugriff (PDF)

Results of the Austrian National Lung Cancer Audit

Clinical Medicine Insights. Oncology, 2020, Vol.14, p.1179554920950548-1179554920950548

2020

Volltextzugriff (PDF)

Urokinase‐type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)‐mediated sodium retention in experimental nephrotic syndrome

Acta Physiologica, 2019-12, Vol.227 (4), p.e13286-n/a

2019

Volltextzugriff (PDF)

A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress

Proceedings of the National Academy of Sciences - PNAS, 2024-01, Vol.121 (4), p.e2317344121-e2317344121

2024

Volltextzugriff (PDF)

Analysis of Factors Relevant to Revenue Enhancement in Hernia Interventions (SwissDRG G09)

Healthcare (Basel), 2021-07, Vol.9 (7), p.862

2021

Volltextzugriff (PDF)

A polycystin-2 protein with modified channel properties leads to an increased diameter of renal tubules and to renal cysts

Journal of cell science, 2021-08, Vol.134 (16)

2021

Volltextzugriff (PDF)

Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19

ESC Heart Failure, 2021-02, Vol.8 (1), p.309-316

2021

Volltextzugriff (PDF)

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.395-400

2014

Volltextzugriff (PDF)

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society

Pneumologie (Stuttgart, Germany), 2011-01, Vol.65 (1), p.39

2011

Volltextzugriff (PDF)

MA15.05 PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S430-S430

2017

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(31)
Humans
(29)
Male
(13)
Middle Aged
(13)
Oncology
(13)
Female
(12)
Physical Sciences
(11)
Aged
(10)
Exact Sciences And Technology
(10)
Adult
(9)
Applied Sciences
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Lung Neoplasms - Drug Therapy
(8)
Organic Polymers
(8)
Physicochemistry Of Polymers
(8)
Polymer Science
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)
Lung Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

The potentially underestimated influence of atrial fibrillation on NT-proBNP in chest pain

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Role and potential of the circular economy in managing end-of-life ships in China

Bildungsprozesse im Ganztag: Wahrnehmung und Wertung erweiterter Bildungsgelegenheiten durch Kinder

Lipophilic Methanethiosulfonate (MTS) Reagents Inhibit Ion Channel Function of Polycystin-2 With a Gain-of-Function Mutation (F604P): FR-PO266

Electrophysiological Characterization of Polycystin-2 Mutants With Disease-Associated Missense Mutations in the Channel's Pore Loop: FR-PO265

Static modelling of the material flows of micro- and nanoplastic particles caused by the use of vehicle tyres

Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

Disease-associated missense mutations in the pore loop of polycystin-2 alter its ion channel function in a heterologous expression system

Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19

Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice

Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19

Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates

Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen

XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice

Results of the Austrian National Lung Cancer Audit

Urokinase‐type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)‐mediated sodium retention in experimental nephrotic syndrome

A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress

Analysis of Factors Relevant to Revenue Enhancement in Hernia Interventions (SwissDRG G09)

A polycystin-2 protein with modified channel properties leads to an increased diameter of renal tubules and to renal cysts

Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society

MA15.05 PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)

Suchergebnisse filtern